| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KDELR3 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1323045 | 6480464 | Ethinyl Estradiol affects the expression of KDELR3 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1323045 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1323045 | 6480464 | Ethinyl Estradiol results in increased expression of KDELR3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1323045 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1323045 | 6480464 | Tetrachlorodibenzodioxin affects the expression of KDELR3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1323045 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KDELR3 mRNA | CTD | PMID:15328365 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1323045 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KDELR3 mRNA | CTD | PMID:17942748 PMID:15328365 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of KDELR3 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of KDELR3 mRNA | CTD | PMID:17138961 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of KDELR3 mRNA | CTD | PMID:21934132 PMID:17138961 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of KDELR3 mRNA | CTD | PMID:17138961 PMID:21934132 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1323045 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of KDELR3 mRNA | CTD | PMID:21715664 |
| cadmium dichloride | affects expression | ISO | RGD:1311536 | 6480464 | Cadmium Chloride affects the expression of KDELR3 mRNA | CTD | PMID:22110744 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of KDELR3 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of KDELR3 mRNA | CTD | PMID:21592394 |
| choline | multiple interactions | ISO | RGD:1323045 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KDELR3 mRNA | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of KDELR3 mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of KDELR3 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of KDELR3 mRNA | CTD | PMID:20106945 |
| cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of KDELR3 mRNA | CTD | PMID:21198554 |
| dibutyl phthalate | decreases expression | ISO | RGD:1311536 | 6480464 | Dibutyl Phthalate results in decreased expression of KDELR3 mRNA | CTD | PMID:21266533 |
| dopamine | increases expression | ISO | RGD:1311536 | 6480464 | Dopamine results in increased expression of KDELR3 mRNA | CTD | PMID:21983523 |
| fenoldopam | increases expression | ISO | RGD:1311536 | 6480464 | Fenoldopam results in increased expression of KDELR3 mRNA | CTD | PMID:21983523 |
| folic acid | multiple interactions | ISO | RGD:1323045 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KDELR3 mRNA | CTD | PMID:20938992 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of KDELR3 mRNA | CTD | PMID:17183730 |
| L-methionine | multiple interactions | ISO | RGD:1323045 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KDELR3 mRNA | CTD | PMID:20938992 |
| paracetamol | affects expression | ISO | RGD:1323045 | 6480464 | Acetaminophen affects the expression of KDELR3 mRNA | CTD | PMID:17562736 |
| phenylephrine | increases expression | ISO | RGD:1311536 | 6480464 | Phenylephrine results in increased expression of KDELR3 mRNA | CTD | PMID:18158353 |
| pirinixic acid | multiple interactions | ISO | RGD:1323045 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KDELR3 mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | ISO | RGD:1311536 | 6480464 | pirinixic acid results in decreased expression of KDELR3 mRNA | CTD | PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:1323045 | 6480464 | pirinixic acid results in decreased expression of KDELR3 mRNA | CTD | PMID:17426115 |
| tamoxifen | affects expression | ISO | RGD:1323045 | 6480464 | Tamoxifen affects the expression of KDELR3 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of KDELR3 mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of KDELR3 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of KDELR3 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | ISO | RGD:1323045 | 6480464 | Carbon Tetrachloride affects the expression of KDELR3 mRNA | CTD | PMID:17484886 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of KDELR3 mRNA | CTD | PMID:17183730 |
| valproic acid | increases expression | ISO | RGD:1323045 | 6480464 | Valproic Acid results in increased expression of KDELR3 mRNA | CTD | PMID:19136453 PMID:21427059 |
| valproic acid | increases expression | ISO | RGD:1323045 | 6480464 | Valproic Acid results in increased expression of KDELR3 mRNA | CTD | PMID:21427059 PMID:19136453 |
| valproic acid | increases expression | ISO | RGD:1323045 | 6480464 | Valproic Acid results in increased expression of KDELR3 mRNA | CTD | PMID:21427059 |